Abivax
Abivax is a clinical-stage biotechnology company, that mobilizes the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Their aim is to use Abivax's drug development platforms to provide novel and effective treatments to patients with large unmet needs in these therapeutic areas.
Tech Stack (22 technologies)
Frequently Asked Questions
What technologies does Abivax use?+
Abivax uses 22 technologies including Font Awesome, Google Analytics, Google Tag Manager.
What industry is Abivax in?+
Abivax operates in the Biotechnology industry.
Where is Abivax based?+
Abivax is headquartered in France.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026